Reference : What is new in anemia treatment in CKD since 2010?
Scientific congresses and symposiums : Unpublished conference/Abstract
Human health sciences : Urology & nephrology
What is new in anemia treatment in CKD since 2010?
Krzesinski, Jean-Marie mailto [Université de Liège - ULiège > Département des sciences cliniques > Néphrologie >]
5ème symposium de dialyse belge
du 17 avril au 19 avril 2012
Fresenius Medical Care
Hargimont (Marche-en-Famenne)
[en] anemia ; treatment ; CKD ; Anémie ; traitement ; IRC
[en] •Partial correction (Hb in the range of 10-11.5 g/dL) of CKD-related anemia appears a safer strategy during the last 5y. So recommendation is to start ESA only when Hb <10 and to avoid too high ESA dose (CE DOSE study ongoing in HD)!
•Identify resistant patients and try to improve it.
•Importance of adequate iron management and of hepcidin role in the all-mortality risk in CKD.
Newer strategies for correcting anemia are currently explored

File(s) associated to this reference

Additional material(s):

File Commentary Size Access
Open access
definFreseniusjemeppe avril 2012.pdf3.05 MBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.